Gait
Conditions
Keywords
toe walker, Pediatric toe walking, ankle flexion
Brief summary
The purpose of this study is to examine the change in ankle plantar flexion while walking, following treatment with the Ankle Dorsiflexion Dynasplint (AFD) for children diagnosed as Toe Walkers. For twelve weeks, patients will either receive the standard treatment or the same standard treatment and the Dynaslint worn at night.
Interventions
OTHERstandard of care treatment
weekly standardized physical therapy and daily wear of an AFO
DEVICEAnkle Flexion Dynasplint
Weekly standardized physical therapy, daily wear of an AFO and nightly wear of the ankle flexion Dynasplint
Sponsors
McMurry University
Dynasplint Systems, Inc.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
* Toe Walking secondary to CP * Idiopathic TW * Inability to ambulate with initial heel-contact * Inability to bear weight and stand flat-footed for over one minute * Inability to stand or hop on one foot (symptomatic) for more than one minute
Exclusion criteria
* Acid Maltase Deficiency Myopathy * Acute Paralytic Poliomyelitis * Spinal Muscular Atrophy-all types * Stroke, ischemic or hemorrhagic, all types * Multiple Sclerosis * Traumatic Brain Injury (including Shaken Baby Syndrome) * Unilateral ROM deficits in Knee or Hip * Previous Achilles Tendon lengthening surgery * Hemiplegic Cerebral Palsy * Muscular Dystrophy-all types
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in plantar flexion while ambulating | 12 weeks | The primary endpoint or dependent variable of this study will be the change in excessive plantar flexion while ambulating. A repeated measures analysis of variance (ANOVA) will be performed to measure kinematic change in gait patterns calculated with an ambulation laboratory test. |
Countries
United States
Outcome results
None listed